- Advertisement -
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders. The intended separation would…
Click here to view the original article.
